Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_assertion type Assertion NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_head.
- NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_assertion description "[As part of our HPV-PathogenISS study, a series of 150 squamous cell carcinomas (SCC) and 152 CIN lesions were examined using immunohistochemical (IHC) staining for topoisomerase IIalpha (topo IIalpha), and tested for HPV using PCR with three primer sets (MY09/11, GP5/GP6, SPF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_provenance.
- NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_assertion evidence source_evidence_literature NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_provenance.
- NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_assertion SIO_000772 16990717 NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_provenance.
- NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_assertion wasDerivedFrom befree-20140225 NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_provenance.
- NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_assertion wasGeneratedBy ECO_0000203 NP440916.RAshO0ENpWDbGDXog3jP8FIwiQKVfCA7_ApnfyGy2L5mE130_provenance.